Mitogens, superantigens, and nominal antigens elicit distinctive patterns of TCRB CDR3 diversity.
The third complementarity-determining region (CDR3) is the only nongermline-encoded hypervariable region of the T cell receptor beta (TCRB) chain, and it is the region that has been predicted to confer fine specificity of the TCR for peptide-MHC complexes. For this reason analysis of TCRB CDR3 heterogeneity may provide insight into immune mechanisms operative in infectious and autoimmune diseases. PBMC stimulated with either mitogen (PHA), superantigen (TSST-1), or nominal antigen (tetanus toxoid) have been compared with unstimulated PBMC using a two-dimensional approach. Analysis of the expressed TCRBV gene repertoire CDR3 length profile coupled with SSCP methodology enabled the discrimination of sequences with the same CDR3 length. For both freshly isolated and PHA stimulated PBMC, a normally distributed spectrum of CDR3 lengths (five or more products) was observed. These products differed by 3 bp (1 amino acid) due to the strict requirement for in-frame rearrangements in the CDR3 region of TCR. By contrast, tetanus toxoid stimulated PBMC had restricted profiles for most TCRBV families after as few as 7 days of incubation. The oligoclonal nature of samples showing CDR3 length restriction was revealed by SSCP analysis and confirmed by sequence determination. Superantigen stimulation resulted in unique patterns of diversity, which included polyclonal expansion of specific TCRBV families as well as oligoclonal expansion of most other TCRBV families. These data reveal complex yet distinct patterns of TCR diversity in response to different T cell activation stimuli.
Currier
J R
JR
Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, Rockville, Maryland 20852, USA.
Deulofeut
H
H
Barron
K S
KS
Kehn
P J
PJ
Robinson
M A
MA
D000328:Adult; D000483:Alleles; D000596:Amino Acids / Q000032:analysis*; D000941:Antigens / Q000276:immunology*; D001427:Bacterial Toxins; D001483:Base Sequence; D002478:Cells, Cultured; D004768:Enterotoxins / Q000276:immunology; D005434:Flow Cytometry; D006801:Humans; D008213:Lymphocyte Activation / Q000276:immunology*; D008934:Mitogens / Q000276:immunology*; D008969:Molecular Sequence Data; D010835:Phytohemagglutinins / Q000276:immunology; D016133:Polymerase Chain Reaction / Q000379:methods; D018807:Polymorphism, Single-Stranded Conformational; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000096:biosynthesis / Q000235:genetics* / Q000276:immunology*; D018089:Superantigens / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*; D013745:Tetanus Toxoid / Q000276:immunology
D000596:Amino Acids; D000941:Antigens; D001427:Bacterial Toxins; D004768:Enterotoxins; D008934:Mitogens; D010835:Phytohemagglutinins; D016693:Receptors, Antigen, T-Cell, alpha-beta; D018089:Superantigens; D013745:Tetanus Toxoid; C030107:enterotoxin F, Staphylococcal